GlassScriptPhysician profile
Justin J Watson
NPI 1760748008
$35,163.44
in general payments reported to CMS, 2019-2025
20 companies · $12K in 2025
The $12K reported for 2025 was more than what 90% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $98.67 · 2020: $418 · 2022: $8,396 · 2023: $12K · 2024: $2,858 · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $12K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,400 · Food and Beverage: $4,989 · Consulting Fee: $2,500 · Travel and Lodging: $1,298.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $12,063.41 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,400.00 |
| Food and Beverage | $4,988.96 |
| Consulting Fee | $2,500.00 |
| Travel and Lodging | $1,297.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $23,363.00 | 2022-2025 | Da Vinci Surgical System, Davinci Xi, Da Vinci Sp |
| Pinnacle Biologics, INC | $9,183.21 | 2023-2025 | Photofrin |
| Abbott Laboratories | $516.80 | 2019-2020 | |
| Tempus Ai, INC | $337.06 | 2024-2025 | Xt Cdx |
| Ethicon INC. | $319.07 | 2022-2023 | |
| Medical Device Business Services, INC. | $230.01 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $180.90 | 2025 | Imfinzi |
| Exelixis INC. | $125.00 | 2025 | Cabometyx |
| Janssen Biotech, INC. | $125.00 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $125.00 | 2025 | Libtayo |
| Jazz Pharmaceuticals INC. | $125.00 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $125.00 | 2025 | |
| Kite Pharma, INC. | $122.16 | 2025 | Yescarta |
| Takeda Pharmaceuticals U.S.A., INC. | $82.50 | 2025 | Fruzaqla |
| Daiichi Sankyo INC. | $58.64 | 2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $45.45 | 2025 | |
| Amgen INC. | $31.25 | 2025 | Vectibix |
| Stemline Therapeutics INC. | $29.41 | 2025 | Orserdu |
| Solventum Corporation | $21.99 | 2024 | V.A.C.Ulta, V.A.C. Veraflo Cleanse Choice, Prevena |
| Ferring Pharmaceuticals INC. | $16.99 | 2024 | Adstiladrin |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Watson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.